Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups
Patents for C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (5,447)
12/2003
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/17/2003CN1131197C Process for preparing 2-alkyl-3-hydroxy-benzoic acid
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101928A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
12/11/2003CA2483817A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
12/10/2003EP1368447A1 Linear compounds containing phenol and salicylic acid units
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1130326C Method for preparing 3-hydroxy-2-methylbenzoic acid
12/09/2003US6660770 Pesticidal activity of functionalized alkenes
12/09/2003US6660755 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003CN1460097A NF-kB inhibitor containing substituted benzoic acid derivative as active ingredient
11/2003
11/27/2003WO2003096996A1 Hair care compositions containing phenolic styling agents
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2003095412A1 2-(α-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE
11/20/2003WO2003006570B1 Novel mesogens and methods for their synthesis and use
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216473 Insecticides, pesticides
11/20/2003US20030215871 Chemically inert molecular tags
11/19/2003EP0927165B1 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/13/2003WO2003093823A2 Chemically inert molecular alkane or oxaalkane-tags and their identification by reaction with fluoroalkanoyl acids
11/13/2003CA2482987A1 Chemically inert molecular alkane or oxaalkane-tags and their identification by reaction with fluoroalkanoyl acids
11/12/2003EP1361216A1 Method of making a HIV-Protease inhibitor
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/06/2003WO2003091196A1 Process for the enantioselective synthesis of propargyl alcohol derivatives of r configuration from the racemic mixtures thereof
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/05/2003CN1453262A Production process of pyrogallic acid
10/2003
10/29/2003EP1357107A1 Indanones and carbamate, and their use in the preparation of arthropodicial oxadiazines
10/28/2003US6639092 Used as charge control agent for an electrophotographic toner and image fixing modifier for inkjet recording paper
10/28/2003US6638977 Biaryl and benzyl ethers and thioethers
10/22/2003EP1032566B9 Method for the preparation of citalopram
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/15/2003EP1351917A1 Stabilised o-iodoxybenzoic acid compositions and preparation method
10/15/2003EP1351907A1 2-butyl-3-(4- 3(dibutylamino)propoxy benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082794A1 A compound as cholinesterase inhibitor and its isolation from fungus sporotrichum species
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/02/2003WO2003080542A2 Method for producing 3-hydroxy-2-methylbenzoic acid
10/02/2003US20030186947 Such as 4-((5-cyclopropyl-methyl-amino)-8,8-dimethyl-5,6,7,8-tetrahydro-naphthalene -2yl-ethynyl)-benzoic acid for treating diseases responsive to treatment by retinoids
10/01/2003EP1202996B1 Titanium derived compounds, preparation and use thereof
09/2003
09/25/2003WO2003006570A3 Novel mesogens and methods for their synthesis and use
09/25/2003US20030180642 Charge control agent, manufacturing process thereof, charge control resin particles and toner for developing electrostatic images
09/24/2003EP1346975A1 Aromatic carboxylic acids, acid halides thereof and processes for preparing both
09/24/2003CN1444591A Method for preparing chromium Ôàó organic complex, its use as corrosion inhibiting agent and as anticorrosive coating agent
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/18/2003US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells
09/18/2003US20030175769 Reagents for improved PCR
09/17/2003CN1443152A production of aromatic carboxylic acids
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121377C Process for producing 2-hydroxynaphthalene-3, 6-dicarboxylic acid
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/11/2003US20030168633 Reacting a difunctional acyl halide with bis 1,4 (4'-hydroxybenzoyloxy)-R2-phenylene and hydroxyalkyls to produce final blend comprising polymerizable mesogens comprising at least three aromatic rings joined by ester linkages
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1093451B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
08/2003
08/28/2003US20030160205 Granule of parahydroxybenzoic acid or parahydroxybenzoic ester and process for producing the same
08/27/2003CN1119324C 3-cyano-2,4.5-trifluoro-benzoyle fluoride and intermediate preparation thereof
08/27/2003CN1119314C Process for preparing salicylic acid by solvent method
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610877 Treating photo and/or age damaged skin
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003CN1436784A Extractant, extraction process and analysis method of high-activity ginkgo leaf extractive
08/20/2003CN1436771A 3-Cyan-2,4,5-trifluoro-benzene formyl fluorine and intermediate produced therefor
08/14/2003US20030153544 Fatty acid derivatives
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/05/2003US6603019 Phenylacetic or heteroarylacetic acid derivatives, retinoic acid inducible enzyme, used to treat diseases responsive to retinoids
08/05/2003US6603012 RAR selective retinoid agonists
07/2003
07/31/2003WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai
07/29/2003US6599867 Overbased detergent additives
07/24/2003US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
07/23/2003EP1328499A2 Method of producing carboxylic acid salts
07/23/2003EP0888278B1 Antidiabetic agents
07/22/2003US6596038 Fuels additives enhance thermal stability; reaction of dodecylphenol, salicylic acid, and formaldehyde to form aromatic aldehyde resin, basic catalyst
07/16/2003CN1430596A New gamma selective retinoids
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322605A1 Method for producing delta 1-pyrrolines
06/2003
06/26/2003US20030120081 Process for the preparation of non-steroidal glucocorticoid receptor modulators
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/24/2003US6583093 Condensates
06/19/2003CA2413669A1 Reagent for improved pcr
06/18/2003EP1319991A2 Charge control agent, manufacturing process thereof, charge control resin particles and toner for developing electrostatic images
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 55